Gasbarrini, Antonio

Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients

Paroni Sterbini, F., Palladini, A., Masucci, L., Cannistraci, C. V., Pastorino, R., Ianiro, G., Bugli, F., Martini, C., Ricciardi, W., Gasbarrini, A., et al. (2016) · Applied and Environmental Microbiology

Helicobacter pylori-related gastroenterology studiesGut microbiota and health

Cited by 108

Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma

Ponziani, F. R., De Luca, A., Picca, A., Marzetti, E., Petito, V., Del Chierico, F., Reddel, S., Paroni Sterbini, F., Sanguinetti, M., Putignani, L., et al. (2022) · Hepatology Communications

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 77

Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms

MONTALTO, M., GALLO, A., SANTORO, L., D’ONOFRIO, F., CURIGLIANO, V., COVINO, M., CAMMAROTA, G., GRIECO, A., GASBARRINI, A., & GASBARRINI, G. (2008) · Alimentary Pharmacology & Therapeutics

Digestive system and related healthGastrointestinal motility and disorders

Cited by 63

First-phase insulin secretion: can its evaluation direct therapeutic approaches?

Di Giuseppe, G., Ciccarelli, G., Soldovieri, L., Capece, U., Cefalo, C. M. A., Moffa, S., Nista, E. C., Brunetti, M., Cinti, F., Gasbarrini, A., et al. (2023) · Trends in Endocrinology & Metabolism

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 46

Small intestinal bacterial overgrowth and intestinal permeability

Lauritano, E. C., Valenza, V., Sparano, L., Scarpellini, E., Gabrielli, M., Cazzato, A., Ferraro, P. M., & Gasbarrini, A. (2010) · Scandinavian Journal of Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 37

LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial

Ciccarese, C., Porcari, S., Buti, S., Fornarini, G., Primi, F., Giudice, G. C., Damassi, A., Giron Berrios, J. R., Stumbo, L., Arduini, D., et al. (2024) · Annals of Oncology

Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers

Cited by 35

Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines

Yao, Y., Tao, H., Kim, J. J., Burkhead, B., Carloni, E., Gasbarrini, A., & Sepulveda, A. R. (2004) · Laboratory Investigation

Genetic factors in colorectal cancerDNA Repair Mechanisms

Cited by 29

Parenteral Nutrition, Inflammatory Bowel Disease, and Gut Barrier: An Intricate Plot

Covello, C., Becherucci, G., Di Vincenzo, F., Del Gaudio, A., Pizzoferrato, M., Cammarota, G., Gasbarrini, A., Scaldaferri, F., & Mentella, M. C. (2024) · Nutrients

Clinical Nutrition and GastroenterologyInflammatory Bowel Disease

Cited by 21

Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank

Ianiro, G., Porcari, S., Bibbò, S., Giambò, F., Quaranta, G., Masucci, L., Sanguinetti, M., Gasbarrini, A., & Cammarota, G. (2021) · Digestive and Liver Disease

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 19